Order Article Reprints

Ras-Jiménez MdM, Ramos-Polo R, Francesch Manzano J, Corbella Santano M, Morillas Climent H, Jose-Bazán N, Jiménez-Marrero S, Garcimartin Cerezo P, Yun Viladomat S, Moliner Borja P, et al. Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients. Journal of Personalized Medicine. 2023; 13(8):1282. https://doi.org/10.3390/jpm13081282

Ras-Jiménez, Maria del Mar, Raúl Ramos-Polo, Josep Francesch Manzano, Miriam Corbella Santano, Herminio Morillas Climent, Núria Jose-Bazán, Santiago Jiménez-Marrero, Paloma Garcimartin Cerezo, Sergi Yun Viladomat, Pedro Moliner Borja, and et al. 2023. "Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients" Journal of Personalized Medicine 13, no. 8: 1282. https://doi.org/10.3390/jpm13081282

Ras-Jiménez, M. d. M., Ramos-Polo, R., Francesch Manzano, J., Corbella Santano, M., Morillas Climent, H., Jose-Bazán, N., Jiménez-Marrero, S., Garcimartin Cerezo, P., Yun Viladomat, S., Moliner Borja, P., Torres Cardús, B., Verdú-Rotellar, J. M., Diez-López, C., González-Costello, J., García-Romero, E., de Frutos Seminario, F., Triguero-Llonch, L., Enjuanes Grau, C., Tajes Orduña, M., & Comin-Colet, J. (2023). Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients. Journal of Personalized Medicine, 13(8), 1282. https://doi.org/10.3390/jpm13081282